Phreesia, Inc. (NYSE:PHR) Given Consensus Recommendation of “Buy” by Analysts

Phreesia, Inc. (NYSE:PHR) has been given a consensus rating of “Buy” by the twelve analysts that are currently covering the firm, MarketBeat.com reports. Twelve equities research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last year is $31.00.

A number of research analysts recently weighed in on PHR shares. Citigroup increased their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Friday, January 10th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price objective for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. Truist Financial increased their target price on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Finally, KeyCorp boosted their price target on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, January 8th.

Phreesia Stock Up 3.8 %

Phreesia stock opened at $27.12 on Thursday. Phreesia has a 12 month low of $17.07 and a 12 month high of $29.16. The stock has a fifty day simple moving average of $23.18 and a two-hundred day simple moving average of $22.71. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04. The firm has a market cap of $1.58 billion, a price-to-earnings ratio of -18.45 and a beta of 0.94.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. The company had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same period last year, the company earned ($0.58) EPS. Equities analysts predict that Phreesia will post -1.16 EPS for the current fiscal year.

Insider Transactions at Phreesia

In related news, SVP Amy Beth Vanduyn sold 1,311 shares of the stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $34,885.71. Following the completion of the sale, the senior vice president now owns 115,633 shares in the company, valued at approximately $3,076,994.13. This trade represents a 1.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michael Weintraub sold 15,152 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $21.01, for a total value of $318,343.52. Following the completion of the transaction, the director now directly owns 242,827 shares in the company, valued at approximately $5,101,795.27. This represents a 5.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 92,962 shares of company stock valued at $2,181,223 over the last three months. Corporate insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. International Assets Investment Management LLC lifted its stake in Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares in the last quarter. Lombard Odier Asset Management USA Corp purchased a new stake in shares of Phreesia in the second quarter worth about $202,000. Point72 DIFC Ltd bought a new position in Phreesia during the second quarter valued at approximately $209,000. XTX Topco Ltd purchased a new position in Phreesia during the 3rd quarter valued at approximately $247,000. Finally, Hsbc Holdings PLC bought a new stake in Phreesia in the 2nd quarter worth approximately $301,000. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.